Literature DB >> 28289215

Selective dietary supplementation in early postpartum is associated with high resilience against depressed mood.

Yekta Dowlati1,2,3, Arun V Ravindran1,2,3, Zindel V Segal4, Donna E Stewart2,3,5, Meir Steiner2,3,6, Jeffrey H Meyer7,2,3.   

Abstract

Medical research is moving toward prevention strategies during prodromal states. Postpartum blues (PPB) is often a prodromal state for postpartum depression (PPD), with severe PPB strongly associated with an elevated risk for PPD. The most common complication of childbearing, PPD has a prevalence of 13%, but there are no widespread prevention strategies, and no nutraceutical interventions have been developed. To counter the effects of the 40% increase in monoamine oxidase A (MAO-A) levels that occurs during PPB, a dietary supplement kit consisting of monoamine precursor amino acids and dietary antioxidants was created. Key ingredients (tryptophan and tyrosine) were shown not to affect their total concentration in breast milk. The aim of this open-label study was to assess whether this dietary supplement reduces vulnerability to depressed mood at postpartum day 5, the typical peak of PPB. Forty-one healthy women completed all study procedures. One group (n = 21) received the dietary supplement, composed of 2 g of tryptophan, 10 g of tyrosine, and blueberry juice with blueberry extract. The control group (n = 20) did not receive any supplement. PPB severity was quantitated by the elevation in depressed mood on a visual analog scale following the sad mood induction procedure (MIP). Following the MIP, there was a robust induction of depressed mood in the control group, but no effect in the supplement group [43.85 ± 18.98 mm vs. 0.05 ± 9.57 mm shift; effect size: 2.9; F(1,39) = 88.33, P < 0.001]. This dietary supplement designed to counter functions of elevated MAO-A activity eliminates vulnerability to depressed mood during the peak of PPB.

Entities:  

Keywords:  monoamine; monoamine oxidase A; postpartum blues; prevention; prodrome

Mesh:

Substances:

Year:  2017        PMID: 28289215      PMCID: PMC5380083          DOI: 10.1073/pnas.1611965114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  51 in total

Review 1.  The therapeutic potential of monoamine oxidase inhibitors.

Authors:  Moussa B H Youdim; Dale Edmondson; Keith F Tipton
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

2.  Cognitive reactivity to sad mood provocation and the prediction of depressive relapse.

Authors:  Zindel V Segal; Sidney Kennedy; Michael Gemar; Karyn Hood; Rebecca Pedersen; Tom Buis
Journal:  Arch Gen Psychiatry       Date:  2006-07

3.  Effect of oestradiol on turnover of type A monoamine oxidase in brain.

Authors:  V N Luine; B S McEwen
Journal:  J Neurochem       Date:  1977-06       Impact factor: 5.372

4.  No effect of oral L-tryptophan or alpha-lactalbumin on total tryptophan levels in breast milk.

Authors:  Yekta Dowlati; Arun V Ravindran; Maxim Maheux; Meir Steiner; Donna E Stewart; Jeffrey H Meyer
Journal:  Eur Neuropsychopharmacol       Date:  2015-03-18       Impact factor: 4.600

5.  A laboratory task for induction of mood states.

Authors:  E Velten
Journal:  Behav Res Ther       Date:  1968-11

Review 6.  Effects and side effects associated with the non-nutritional use of tryptophan by humans.

Authors:  John D Fernstrom
Journal:  J Nutr       Date:  2012-10-17       Impact factor: 4.798

7.  Tissue-specific effects of estrogen on monoamine oxidase A and B in the rat.

Authors:  D P Holschneider; T Kumazawa; K Chen; J C Shih
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

8.  Can we identify mothers at risk for postpartum depression in the immediate postpartum period using the Edinburgh Postnatal Depression Scale?

Authors:  Cindy-Lee Dennis
Journal:  J Affect Disord       Date:  2004-02       Impact factor: 4.839

9.  Serotonin 1A receptor reductions in postpartum depression: a positron emission tomography study.

Authors:  Eydie L Moses-Kolko; Katherine L Wisner; Julie C Price; Sarah L Berga; Wayne C Drevets; Barbara H Hanusa; Tammy L Loucks; Carolyn C Meltzer
Journal:  Fertil Steril       Date:  2007-06-04       Impact factor: 7.329

Review 10.  Psychosocial and psychological interventions for preventing postpartum depression.

Authors:  Cindy-Lee Dennis; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28
View more
  6 in total

Review 1.  Stress, sex hormones, inflammation, and major depressive disorder: Extending Social Signal Transduction Theory of Depression to account for sex differences in mood disorders.

Authors:  George M Slavich; Julia Sacher
Journal:  Psychopharmacology (Berl)       Date:  2019-07-29       Impact factor: 4.530

2.  Short-term oestrogen as a strategy to prevent postpartum depression in high-risk women: protocol for the double-blind, randomised, placebo-controlled MAMA clinical trial.

Authors:  Stinne Høgh; Hanne Kristine Hegaard; Kristina Martha Renault; Eleonora Cvetanovska; Anette Kjærbye-Thygesen; Anders Juul; Camilla Borgsted; Anne Juul Bjertrup; Kamilla Woznica Miskowiak; Mette Skovgaard Væver; Dea Siggaard Stenbæk; Vibeke Høyrup Dam; Elisabeth Binder; Brice Ozenne; Divya Mehta; Vibe G Frokjaer
Journal:  BMJ Open       Date:  2021-12-30       Impact factor: 3.006

Review 3.  Promising leads and pitfalls: a review of dietary supplements and hormone treatments to prevent postpartum blues and postpartum depression.

Authors:  Yekta Dowlati; Jeffrey H Meyer
Journal:  Arch Womens Ment Health       Date:  2020-11-17       Impact factor: 3.633

4.  Novel urinary metabolite signature for diagnosing postpartum depression.

Authors:  Lin Lin; Xiao-Mei Chen; Rong-Hua Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2017-05-10       Impact factor: 2.570

5.  Depressed mood induction in early cigarette withdrawal is unaffected by acute monoamine precursor supplementation.

Authors:  Yekta Dowlati; Danilo R de Jesus; Peter Selby; Ian Fan; Jeffrey H Meyer
Journal:  Neuropsychiatr Dis Treat       Date:  2019-01-23       Impact factor: 2.570

6.  Differential expression of IL-6/IL-6R and MAO-A regulates invasion/angiogenesis in breast cancer.

Authors:  Rashmi Bharti; Goutam Dey; Anjan Kumar Das; Mahitosh Mandal
Journal:  Br J Cancer       Date:  2018-04-26       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.